Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 16 Aug 2021
Government of Canada negotiates additional agreement with Moderna for vaccine supply beyond 2021
13 August 2021 - The Government of Canada is committed to protecting the health and safety of Canadians by securing ...
Posted by Michael Wonder on 16 Aug 2021
Artificial intelligence in medicine regulation
16 August 2021 - The International Coalition of Medicines Regulatory Authorities sets out recommendations to help regulators to address the ...
Posted by Michael Wonder on 16 Aug 2021
InxMed's IN10018 receives U.S. FDA fast track designation for the treatment of platinum-resistant ovarian cancer
16 August 2021 - InxMed announced today the U.S. FDA has granted fast track designation to IN10018 for the treatment of ...
Posted by Michael Wonder on 16 Aug 2021
U.S. FDA approves Ticovac, Pfizer's tick borne encephalitis vaccine
13 August 2021 - Ticovac may help reduce the risk of tick-borne encephalitis for people traveling to endemic areas, potentially including ...
Posted by Michael Wonder on 15 Aug 2021
Australia secures one million Pfizer doses from Poland, with more than half destined for Sydney
15 August 2021 - Poland has come to Australia’s rescue with an extra one million Pfizer doses after the government went ...
Posted by Michael Wonder on 15 Aug 2021
PHARMAC invites entire staff to top secret drug ranking meetings
16 August 2021 - Highly confidential meetings where PHARMAC ranks the funding priority of potentially life-saving medicines are open to ...
Posted by Michael Wonder on 15 Aug 2021
Coronavirus (COVID-19) update: FDA authorises additional vaccine dose for certain immunocompromised individuals
12 August 2021 - Other fully vaccinated individuals do not need an additional vaccine dose right now. ...
Posted by Michael Wonder on 14 Aug 2021
Sesen Bio receives complete response letter from FDA for Vicineum (oportuzumab monatox-qqrs)
Sesen Bio today announced that it received a complete response letter from the U.S. FDA regarding its biologics license application ...
Posted by Michael Wonder on 14 Aug 2021
Genomic diagnostic tests face persistent pricing and reimbursement challenges
13 August 2021 - Twenty years ago, the mapping of the human genome promised new opportunities for genomic or genetic tests ...
Posted by Michael Wonder on 14 Aug 2021
Halifax man devastated after insurer reverses decision to cover $25,000 cystic fibrosis drug
13 August 2021 - Stefan Strecko says he's pleaded with Canada Life to cover cost of 'miracle' drug. ...
Posted by Michael Wonder on 14 Aug 2021
Ipsen announces withdrawal of palovarotene NDA, confirming intention to resubmit following additional data analyses
13 August 2021 - This follows ongoing dialogue with the U.S. FDA regarding the palovarotene NDA review, initiated in May ...
Posted by Michael Wonder on 13 Aug 2021
FDA approves belzutifan for cancers associated with von Hippel-Lindau disease
13 August 2021 - Today the FDA approved belzutifan (Welireg, Merck), a hypoxia-inducible factor inhibitor for adult patients with von ...
Posted by Michael Wonder on 13 Aug 2021
Congress should fix FDA’s accelerated approval program for the next 30 years
12 August 2021 - The FDA's approval of the Alzheimer’s drug Aduhelm has sparked a broader debate on the merits ...
Posted by Michael Wonder on 13 Aug 2021
Making vaccines available to other countries before offering domestic booster vaccinations
12 August 2021 - On July 8, 2021, Pfizer and BioNTech announced they would be seeking US and European authorisation ...
Posted by Michael Wonder on 13 Aug 2021
GC Pharma announces GreenGene F approval in China for the treatment of haemophilia A
12 August 2021 - GreenGene F now approved in China, provides more haemophilia A patients access to proven therapy. ...